Grammy Award-Winning Artist Fergie Shows Her Support for CureDuchenne with a New Public Service Announcement
Newport Beach, Calif.
NEWPORT BEACH, Calif., September 4, 2013— CureDuchenne, a national nonprofit organization that raises awareness and funds research for Duchenne muscular dystrophy, announced today that Fergie, the eight-time Grammy award-winning singer/songwriter, is appearing in a new public service announcement (PSA) campaign on behalf of the organization. The PSA is part of CureDuchenne’s efforts to raise awareness of Duchenne, the most common and lethal form of muscular dystrophy, and raise funds to develop a robust pipeline of therapies that target the disease from every angle. Currently there is no treatment for Duchenne. Boys with Duchenne are usually diagnosed before the age of five and are in a wheelchair by age 12; most don’t survive their mid-20s.
Best known as the female vocalist for the hip hop group The Black Eyed Peas, Fergie and her husband, actor Josh Duhamel, became new parents on August 29 when their son Axl Jack was born.
“CureDuchenne is thrilled to launch this PSA with the support of a talented and respected artist such as Fergie,” said Debra Miller, CEO and Founder, CureDuchenne. “Real progress toward a cure is being made, but we urgently need the public’s continued support to help us accelerate the discovery and development of possible new treatments for this terrible disease.”
The 30-second PSA can be viewed online on CureDuchenne’s website and YouTube channel. Click here to view.
CureDuchenne already has raised more than $11 million toward promising research aimed at treating and curing Duchenne, and has advanced seven research projects to-date into human clinical trials. CureDuchenne’s research investments have leveraged more than $100 million from biotech and pharmaceutical companies, venture capital funds and other foundations to fund research leading to a cure.
CureDuchenne is a national nonprofit organization dedicated to finding a cure for Duchenne, the most common and most lethal form of muscular dystrophy. As the leading genetic killer of young boys, Duchenne affects more than 300,000 boys worldwide.CureDuchenne has garnered international attention for its efforts to raise funds and awareness for Duchenne through venture philanthropy. For more information on how to help raise awareness and funds needed for research, visit www.cureduchenne.org.